<ARTICLE> 5 <LEGEND> THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR THE PERIOD ENDED DECEMBER 26, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000925054 <NAME> SPECTRIAN CORP /DE/ <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> MAR-31-2000 <PERIOD-START> APR-01-1999 <PERIOD-END> DEC-26-1999 <CASH> 13,163 <SECURITIES> 36,116 <F1> <RECEIVABLES> 33,842 <ALLOWANCES> 417 <INVENTORY> 26,261 <CURRENT-ASSETS> 113,614 <PP&E> 64,694 <DEPRECIATION> 43,840 <TOTAL-ASSETS> 134,468 <CURRENT-LIABILITIES> 30,052 <BONDS> 1,659 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 12 <OTHER-SE> 102,745 <TOTAL-LIABILITY-AND-EQUITY> 134,468 <SALES> 123,595 <TOTAL-REVENUES> 123,595 <CGS> 95,763 <TOTAL-COSTS> 95,763 <OTHER-EXPENSES> 16,039 <F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 419 <INCOME-PRETAX> 584 <INCOME-TAX> 74 <INCOME-CONTINUING> 510 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 510 <EPS-BASIC> 0.05 <F3> <EPS-DILUTED> 0.05 <FN> <F1> Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss. <F2> Item consists of research and development. <F3> Item consists of basic earnings per share. </FN>